A detailed history of Mascagni Wealth Management, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mascagni Wealth Management, Inc. holds 167 shares of BMY stock, worth $10,023. This represents 0.01% of its overall portfolio holdings.

Number of Shares
167
Holding current value
$10,023
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Mar 21, 2025

BUY
$51.92 - $59.94 $8,670 - $10,009
167 New
167 $9.45 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $128B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Mascagni Wealth Management, Inc. Portfolio

Follow Mascagni Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mascagni Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mascagni Wealth Management, Inc. with notifications on news.